These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 37149357)

  • 1. Immunodeficiency-Associated Epstein-Barr Virus-Positive B-cell Lymphoproliferative Disorders: A Review and New Paradigm.
    Chapman J
    Surg Pathol Clin; 2023 Jun; 16(2):213-231. PubMed ID: 37149357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related EBV-associated B-cell lymphoproliferative disorders and other EBV + lymphoproliferative diseases: New insights into immune escape and immunodeficiency through staining with anti-PD-L1 antibody clone SP142.
    Sakakibara A; Kohno K; Ishikawa E; Suzuki Y; Shimada S; Eladl AE; Elsayed AA; Daroontum T; Satou A; Takahara T; Ohashi A; Takahashi E; Kato S; Nakamura S; Asano N
    Pathol Int; 2020 Aug; 70(8):481-492. PubMed ID: 32367595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epstein-Barr virus infection and lymphoproliferative disorders].
    Isobe Y
    Rinsho Ketsueki; 2020; 61(9):1286-1296. PubMed ID: 33162528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?
    Natkunam Y; Gratzinger D; Chadburn A; Goodlad JR; Chan JKC; Said J; Jaffe ES; de Jong D
    Blood; 2018 Nov; 132(18):1871-1878. PubMed ID: 30082493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senile Epstein-Barr virus-associated B-cell lymphoproliferative disorders: a mini review.
    Shimoyama Y; Oyama T; Asano N; Oshiro A; Suzuki R; Kagami Y; Morishima Y; Nakamura S
    J Clin Exp Hematop; 2006 Mar; 46(1):1-4. PubMed ID: 17058802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: a review.
    Marques-Piubelli ML; Salas YI; Pachas C; Becker-Hecker R; Vega F; Miranda RN
    Pathology; 2020 Jan; 52(1):40-52. PubMed ID: 31706670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How I Diagnose EBV-Positive B- and T-Cell Lymphoproliferative Disorders.
    Dojcinov SD; Quintanilla-Martinez L
    Am J Clin Pathol; 2023 Jan; 159(1):14-33. PubMed ID: 36214507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr Virus-Positive Extranodal Marginal Zone Lymphoma of Bronchial-Associated Lymphoid Tissue in the Posttransplant Setting: An Immunodeficiency-Related (Posttransplant) Lymphoproliferative Disorder?
    Cassidy DP; Vega F; Chapman JR
    Am J Clin Pathol; 2017 Dec; 149(1):42-49. PubMed ID: 29228090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseases.
    Fujimoto K; Hatanaka KC; Hatanaka Y; Kasahara I; Yamamoto S; Tsuji T; Nakata M; Takakuwa Y; Haseyama Y; Oyamada Y; Yonezumi M; Suzuki H; Sakai H; Noguchi H; Mori A; Nishihara H; Teshima T; Matsuno Y
    Hematol Oncol; 2020 Dec; 38(5):799-807. PubMed ID: 32798315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological findings, prognosis, and Epstein-Barr virus infection in rheumatoid arthritis patients with other iatrogenic immunodeficiency-associated T- and NK-cell lymphoproliferative disorders.
    Kimura S; Oshiro Y; Iwasaki H; Kadowaki M; Ogata M; Daa T; Sakata T; Kawauchi S; Wang Z; Takamatsu Y; Takeshita M
    BMC Cancer; 2022 Dec; 22(1):1342. PubMed ID: 36544095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
    Hue SS; Oon ML; Wang S; Tan SY; Ng SB
    Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders.
    Quintanilla-Martinez L; Swerdlow SH; Tousseyn T; Barrionuevo C; Nakamura S; Jaffe ES
    Virchows Arch; 2023 Jan; 482(1):227-244. PubMed ID: 36216980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Understanding the Pathogenesis of Epstein-Barr Virus-Associated Lymphoproliferative Disorders.
    Yang X; Nishida N; Zhao X; Kanegane H
    Iran J Allergy Asthma Immunol; 2015 Oct; 14(5):462-71. PubMed ID: 26742434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
    Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
    Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of age-related Epstein-Barr virus (EBV)-associated B cell lymphoproliferative disorder, so-called polymorphous subtype, of the mandible, with a review of the literature.
    Kikuchi K; Fukunaga S; Inoue H; Miyazaki Y; Kojima M; Ide F; Kusama K
    Head Neck Pathol; 2013 Jun; 7(2):178-87. PubMed ID: 22869357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced PD-L1 Expression in LMP1-positive Cells of Epstein-Barr Virus-associated Malignant Lymphomas and Lymphoproliferative Disorders: A Single-cell Resolution Analysis With Multiplex Fluorescence Immunohistochemistry and In Situ Hybridization.
    Kume A; Shinozaki-Ushiku A; Kunita A; Kondo A; Ushiku T
    Am J Surg Pathol; 2022 Oct; 46(10):1386-1396. PubMed ID: 35605962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
    Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
    Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr Virus-Associated Lymphoproliferative Disorders: Review and Update on 2016 WHO Classification.
    Kim HJ; Ko YH; Kim JE; Lee SS; Lee H; Park G; Paik JH; Cha HJ; Choi YD; Han JH; Huh J;
    J Pathol Transl Med; 2017 Jul; 51(4):352-358. PubMed ID: 28592786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anterior segment involvement in Epstein-Barr virus: a review.
    Alba-Linero C; Rocha-de-Lossada C; Rachwani-Anil R; Sainz-de-la-Maza M; Sena-Corrales G; Romano V; Rodríguez-Calvo-de-Mora M
    Acta Ophthalmol; 2022 Aug; 100(5):e1052-e1060. PubMed ID: 34766457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
    Kingma DW; Weiss WB; Jaffe ES; Kumar S; Frekko K; Raffeld M
    Blood; 1996 Jul; 88(1):242-51. PubMed ID: 8704180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.